Quentin Pankhurst
Director/Board Member at The Royal Institution of Great Britain
Quentin Pankhurst active positions
| Companies | Position | Start |
|---|---|---|
| University College London | Corporate Officer/Principal | 2011-07-20 |
| Davy-Faraday Research Laborator | Director/Board Member | 2011-07-20 |
The Royal Institution of Great Britain
 The Royal Institution of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Institution of Great Britain is a charitable organization that is dedicated to connecting people with the world of science. | Director/Board Member | 2011-07-20 |
Former positions of Quentin Pankhurst
| Companies | Position | End |
|---|---|---|
| University of California, Los Angeles | Corporate Officer/Principal | - |
Endomagnetics Ltd.
 Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Founder | - |
Training of Quentin Pankhurst
| The University of Liverpool | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
The Royal Institution of Great Britain
The Royal Institution of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Institution of Great Britain is a charitable organization that is dedicated to connecting people with the world of science. | Commercial Services |
Endomagnetics Ltd.
Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
| Davy-Faraday Research Laborator |
- Stock Market
- Insiders
- Quentin Pankhurst
